Trinity Biotech plc (TRIB) Implosion a Boon to Short Sellers

Trinity Biotech plc (ADR) (TRIB) has lost nearly half its value today

Oct 4, 2016 at 12:01 PM
facebook twitter linkedin


After being halted earlier, Trinity Biotech plc (ADR) (NASDAQ:TRIB) has gotten demolished, shedding nearly half its value to trade at $6.76. The percentage loss -- which is the biggest of any Nasdaq stock -- was triggered after the diagnostic device maker withdrew its marketing application for a pair of products and announced plans to cut spending. Moreover, earlier TRIB touched a six-year low of $5.76.

Amid the volatility, the stock's intraday volume has already touched an annual peak. The same goes for options volume -- though, on an absolute basis, volume is relatively light, at just 328 contracts on the tape. Plus, TRIB's 30-day at-the-money implied volatility has spiked 127.1% to a 12-month high of 116.5%.

In case there were any doubts, TRIB is on the short-sale restricted list today. However, there are still plenty of bearish bets on the shares. Nearly 8% of the stock's float is sold short, the highest level since February. And, at the equity's average daily volumes, it would take approximately seven weeks to cover these positions. Suffice it to say, these doubters are now sitting pretty.

The brokerage crowd has taken a far more hopeful approach. Six of seven analysts tracking Trinity Biotech plc (ADR) (NASDAQ:TRIB) rate it a "buy" or better, compared to one "hold" and not a single "sell." Plus, the stock's average 12-month price target of $17.50 rests in territory not charted since July 2015. From a contrarian perspective, a well-deserved round of downgrades and/or price-target reductions could trigger TRIB's next leg lower.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

SCHAEFFER'S JULY STOCKS REPORT AD
 


 


 
Special Offers from Schaeffer's Trading Partners